// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























229 Abstracts

RHEUMATOID ARTHRITIS ACTIVITY BEFORE AND AFTER COVID-19 LOCKDOWN PERIOD

M. Jordhani - European League Against Rheumatism (EULAR) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

SCD POPULATION SURVEY IN ALBANIA, A PROSPECTIVE NON-INTERVENTIONAL MULTI-CENTER STUDY EVALUATING DISEASE AND PATIENTS CHARACTERISTICS OF SICKLE CELL DISEASE IN ALBANIAN SCD POPULATION

Alma Cili - European Hematology Association (EHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Sickle cell anemia

N/A

REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION

Adela Perolla - European Hematology Association (EHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Myelofibrosis

Ruxolitinib phosphate

OVERALL SURVIVAL OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB IN ALBANIA ( 2018-2022)

Elsuarta Calliku - European Hematology Association (EHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Chronic Lymphocytic Leukemia

Ibrutinib

A CLINICAL STUDY ON MYELODYSPLASTIC SYNDROMES

Adela Perolla - European Hematology Association (EHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Myelodysplastic Syndrome

N/A

OUTCOMES IN PATIENTS WITH FOLLICULAR LYMPHOMA AND CHRONIC LYMPHOID LEUKEMIA RECEIVING OBINUTUZUMAB, IN THE SETTING OF COVID19 INFECTION

Adela Perolla - European Hematology Association (EHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Chronic Lymphocytic Leukemia

Obinutuzumab

EPIDEMIOLOGY OF ACQUIRED APLASTIC ANEMIA: A RETROSPECTIVE 10-YEAR SINGLE CENTRE EXPERIENCE

Liri Seraj - European Hematology Association (EHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Aplastic anemia

N/A

Periferic located masses and the role of EBUS-TBNA and EUS–B-FNA

Eritjan Tashi - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Is it Time for Endobronchial Therapy to Replace Surgery in the Treatment of Typical Endobronchial Carcinoid?

Alma Teferici - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intestinal carcinoid tumor

N/A

Clinical in-hospital mortality profile of pulmonary embolism

Loreta Agolli - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary embolism

N/A

Antiphospholipid syndrome in patients with acute myocardial infarction

M. Jordhani - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Myocardial infarction

N/A

Incidence, severity and outcome of acute kidney injury according to KDIGO criteria between intensive care unit patients

Albana Gjyzari - Global Nephrologists Annual Meeting , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

The mortality predicting factors at admission and during hospitalisation of pateints with SARS COV2

Perlat Kapisyzi - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Can lung function tests help identify functional phenotypes in children with asthma?

Sonila Borici - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Minding the gap between improved economical status and increased preterm births: trends of preterm births in a tertiary centre in Albania

A. Shtylla - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous preterm delivery

N/A

Case study of the diagnostic challenge of a solitary peritoneal leiomyoma

K. Zyka - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Fetal macrosomia: risk factors, maternal and neonatal outcome

L.F. Zijaj - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Fetal macrosomia

N/A

A rare case of a complete tubal abortion

E. Dema - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Ectopic pregnancy

N/A

OUTCOME OF LAPAROSCOPY VS LAPAROTOMY IN MANAGEMENT OF BENIGN OVARIAN CYSTS

Arlinda Elmasllari - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Gastric cancer in Albania: Epidemiological, clinical and pathological characteristics

F. Kraja - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gastric Cancer

N/A

Copyright © 2026. QuantiNova All rights reserved